American Association for Cancer Research

Table 2

Correlations among levels of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (trans, anti-PheT), r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo(a)pyrene (trans, anti-BaP-tetraol) and 1-hydroxypyrene in urine

Group	trans, anti-PheT/1-hydroxypyrene	trans, anti-PheT/trans, anti-BaP-tetraol	1-hydroxypyrene/ trans, anti-BaP-tetraol
Psoriasis patients (n = 20)	R = 0.22	R = 0.13	R = 0.37
	P = 0.35	P = 0.58	P = 0.11
Coke oven workers (n = 32)	R = 0.54	R = 0.33	R = 0.68
	P = 0.002	P = 0.06	P < 0.0001^a
Smokers (n = 31)	R = 0.35	N.A.^b	N.A.
	P = 0.05
Nonsmokers (n = 30)	R = 0.47	N.A.	N.A.
	P = 0.009

Group	trans, anti-PheT/1-hydroxypyrene	trans, anti-PheT/trans, anti-BaP-tetraol	1-hydroxypyrene/ trans, anti-BaP-tetraol
Psoriasis patients (n = 20)	R = 0.22	R = 0.13	R = 0.37
	P = 0.35	P = 0.58	P = 0.11
Coke oven workers (n = 32)	R = 0.54	R = 0.33	R = 0.68
	P = 0.002	P = 0.06	P < 0.0001^a
Smokers (n = 31)	R = 0.35	N.A.^b	N.A.
	P = 0.05
Nonsmokers (n = 30)	R = 0.47	N.A.	N.A.
	P = 0.009

From Ref. 35.

N.A., not analyzed because levels of trans, anti-BaP-tetraol were not determined in these samples.

View Large

This Feature Is Available To Subscribers Only